Organigram Global (OGI) Other financing activities (2018 - 2026)

Organigram Global (OGI) posted quarterly Other financing activities of $4375.2 for Q1 2026, up 1.69% on a QoQ basis from $4302.5 in Q4 2025.

Organigram Global (OGI) Other financing activities (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Other financing activities for 6 consecutive years, with $4375.2 the latest figure, recorded in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $4375.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (changed N/A YoY) and the FY2021 annual result came in at $17000.0, changed N/A from the prior year.
Other financing activities grew to $4375.2 in Q1 2026 per OGI's latest filing, from $4302.5 in the prior quarter.
Over the last five years, Other financing activities for OGI reached as high as $4375.2 in Q1 2026 and fell as low as $4302.5 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Organigram Global	89.89 Mn	122.96 Mn	28.97 Mn

Download Data